Peripheral primitive neuroectodermal tumor with postchemotherapy neuroblastoma-like differentiation

Pediatr Dev Pathol. 2006 May-Jun;9(3):229-33. doi: 10.2350/06-01-0018.1.

Abstract

We report the case of an 11-year-old girl with a retroperitoneal tumor in the left upper quadrant. The girl was admitted to hospital with weight loss and a painless abdominal mass that on biopsy was diagnosed as a peripheral primitive neuroectodermal tumor/Ewing sarcoma (pPNET/EWS) of the soft tissue. The patient underwent chemotherapy followed by surgical resection of the tumor 5 months after diagnosis. The posttreatment residual viable tumor showed a morphologic appearance resembling a neuroblastoma. Interphase and metaphase fluorescent in situ hybridization (FISH) studies performed on the pretreatment and posttreatment samples showed the presence of a t(11;22) rearrangement resulting in EWSR1/FLI1 gene fusion consistent with pPNET/EWS in both specimens. This case is unusual in the sense of showing the typical gene fusion for pPNET/EWS both in the pretherapy sample with the typical morphological appearance of this tumor and in the posttherapy specimen showing neural differentiation suggestive of a neuroblastoma.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cell Differentiation*
  • Child
  • Chromosomes, Human, Pair 11
  • Chromosomes, Human, Pair 22
  • Cyclophosphamide / therapeutic use
  • Dactinomycin / therapeutic use
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • In Situ Hybridization, Fluorescence
  • Karyotyping
  • Neuroblastoma / physiopathology*
  • Neuroectodermal Tumors, Primitive, Peripheral / diagnosis
  • Neuroectodermal Tumors, Primitive, Peripheral / drug therapy*
  • Neuroectodermal Tumors, Primitive, Peripheral / genetics
  • Neuroectodermal Tumors, Primitive, Peripheral / metabolism
  • Neuroectodermal Tumors, Primitive, Peripheral / pathology
  • Neuroectodermal Tumors, Primitive, Peripheral / physiopathology*
  • Neuroectodermal Tumors, Primitive, Peripheral / radiotherapy
  • Neuroectodermal Tumors, Primitive, Peripheral / surgery
  • Oncogene Fusion
  • Radiotherapy, Adjuvant
  • Time Factors
  • Tomography, X-Ray Computed
  • Translocation, Genetic
  • Vincristine / therapeutic use

Substances

  • Dactinomycin
  • Vincristine
  • Cyclophosphamide

Supplementary concepts

  • VAC protocol